NICE have partnered with the USA-based Institute for Clinical and Economic Review (ICER) and the Canadian Drug Agency (CDA-AMC) to establish the Health Economics Methods Advisory (HEMA), a new international initiative to research and assess health technology assessment (HTA) methods. HEMA’s aim is to critically and independently research some of the most pressing topics in global health economics and health…
Ben KempFebruary 24, 2025